Bridging the Gap: Index Volume [International Conference on AIDS (12th: 1998: Geneva, Switzerland)]

12th World AIDS Conference

general Germany 71

are workers (HCW) in a
HIV-infected patients in
d practises of allopathic
mous counselling to the
or C6te d'lvoire to draw
tiretroviral (ARV) use in
sons who speak to the
table HIV epidemics in
apeutic optimism in the
ent: Decision-making in
w sexual encounters: A

Keyword
hospital/Pyschosocial impa
practices in deprived and nc
practitioners in the provision
public through an interactive
public's attention to AIDS/T
practice in urban Zambia: pr
public with their faces uncov
population in Senegal: Wha
public?/Does safer sex sun
practice/Initiation of antiretr
population study in Switzerl

Abstract -
ct of o 24307
)n-dep 32431
I of ST 33243
Svoice 139*/33473
wo col 33506
oblem 42318,ered: 43375
it do w 43441
vive th 43514
oviral t 60310
and/E 60733
nporta 43166
ort gro 43212
H/A on 34278
es oft 11101
CTLb 31150
transc 12214
s to in 34144: Resu 41113
and a 42126
vith im 42158
iving c 12257
olates 31199

-Keyword

Itifactorial approach to generate male involvement as an ir
supervision of income - Generatiing projects by PWA supp(
LWH/A project/Income generating activities amongst PLWF
o-inflammatory activity/ Generation of recombinant analogu
ogeneic dendritic cells/ of HIV-epitope-specific
hase I study/A second generation non-nucleoside reverse
d nations using income programmes as subsidie
ests~ HIV combi/A new of HIV-diagnostic assay
rimary infection/A new test associating antigen
valuation of two second HIV-1 viral load assays \
of the RT and protease genes in HIV-infected children recei
cytomegalovirus UL97 from GCV-resistant clinical is(

Abstract--

isease associated with mycoplasma and streptococci spe 60882
n San Martino Hospital, Genoa,Italy/Evaluation of occupational ex 13471
hypermutation on HIV-1 genome /Possible restrictions of G--A hy 11200
ear localization of HIV-1 /Novel anti-retroviral compounds 12370
tion of integrated HIV-1 genomes in cell culture by CpG methylatio 11127
ning of full-length HIV-1 from recent infections in India: R 11194
mportant herpesvirus /A multiplex nested PCR assay f 41151
ase mutations in HIV-1 detected in plasma and blood m 41217
f full-length HIV-1 RNA genomic sequences in the genital tract of 11169
apy upon HIV mucosal and mRNA/Different effects of di 32112
exposed infants/CCR5 genotype and HIV-1 infection in perinatall 215*/13365
1 transmission/CCR-5 may confer resistance to mother 11*/21107
kine receptor 5 (CCR5) in long-term survivors of HIV-1 i 31114
age: Influence of CCR5 and antiretroviral treatment/Cyt 31138
ine receptor 5 (CCR5) in highly exposed but persistentl 31147
ican-Americans/MHC predicts disease progression an 60870
A, C and D recombinant genotypes from perinatally infected infant 13115
tina/At least four HIV-1 circulate in Rosario, Argentina 13175
Hepatitis C virus (HCV) and progression of HIV infectio 13306
s/Chemokine receptor and HIV disease progression: 13311
5, and/or CCR2-+/641 /Longitudinal studies on a coho 13353
iosis/Determination of of enterocytozoon bieneusi str 22235
ssion/Prevalence and of hepatitis G virus and hepatiti 22264
envelope glycoprotein of CMV strains isolated from sa 31203
scriptase and protease in patients with HIV-1 symptom 60316
uth African gold mines/ Genotypic and phenotypic characterizatio 13122
lood and genital fluid/ and biotypic characterization of 21157
ng-term monotherapy/ and phenotypic resistance to st 32285
retrospective analysis/ analysis for resistance testing ( 32292
r AZT and 3TC therapy/ and phenotypic resistance in H 32298
g combination therapy/ resistance patterns in HIV-infe 32304
ir combination therapy/ and phenotypic analysis of HIV 32312
eatment-naive patients/ resistance in treatment-naive p 32313
ciency virus in Ukraine/ analysis of human immunodefi 41161
gion of seroconverters/ prevalence of transmitted ZDV 41210
susceptibility to PMPA/ changes in HIV RT which devel 41218
fferential hybridization/ analysis of the HIV-1 reverse tr 60317
d to existing regimens/ characterization of HIV-1 isolat 60706
HAART)/Detection of genotypic drug resistance to antiviral nucl 233*/32282
nical cohort study/HIV predictors of antiviral response 229*/32287
D4+ outcome following antiretroviral resistance testing 32291
ponse/Application of a driven rule-based expert artifici 32297
resistance-associated mutations in plasma HIV of pati 32301
erns of phenotypic and cross-resistance among protea 230*/42195
navir/Low frequency of mutations associated with resis 42197

w disease progression/ Genetic evolution of HIV-1 subtype A in Afr
ains identified in China/ recombination of HIV-1 strains ide
e with unusual V3 loop/ and biological characterization of
exposure of macaques/ characteristics of SIV after intrave
MA)forHIV-1 subtyping/ diversity of HIV-1 in Tanzania: Us
1 in Myanmar (Burma)/ and serologic characterization of
) in Bangkok, Thailand/ characterization of incident HIV-1
converters in Thailand/ diversity of HIV-1 subtype E from r
ovel A/B recombinant/ characterization of HIV-1 in Russi
osi's sarcoma tumours/ abnormalities in Kaposi's sarcom
HIV-2 infected women/ characterization of viral quasi-spe
r epidemiology of HIV-1 genetic subtypes in West and Central Afric
mary isolates of different subtypes/Chemokine receptor us
IV-1 virions of different subtypes (clades) by a new virus-b
navir therapy causes a drift in the env quasi-species/Hum
Comparative analysis of diversity among seropositive popu
group O/Analysis of the diversity of HIV-1 group O/Analysi
AIDS/Determination of subtypes of HIV-1 from Korean pat
resence of two distinct subtypes/Molecular characterizati
ic in Kaliningrad/HIV-1 subtype A/B recombinant strain ca
site for monitoring HIV diversity in the United States/Prev
ssors in France/Host's background of HIV-1 infected long
d infants/Viral and host characterization of possible transi
V-1 RNA from different subtypes/Efficiency of three versi
ue of HIV load and host factor on disease progression rate
Island/Serological and characterization of HIV-1 subtype
ulating HIV-1 and HIV-2 subtypes in Spain/Circulating HIV
s/In vivo persistence of genetically modified, HIV-1-specific syng
e issues - "The Road to Geneva "/End of Life issues - "The Road to

11173
429*/11179
11204
11221
13110
13130
13133
13155
13194
22284
60652
430*/11163
9*/11166
11178
11185
11188
11195
11201
12178
13190
13225
12*/13346
23312
41145
42146
60543
60681
346*/42322
44*/22438

evention among IDU in
mmigrant community in
g migrant sex workers in
intenance treatment in
ndromic management/
IV counseling in Brazil/
genital tract of women:
te vaginal microbicide/
ning clients in Guyana/
V-1 in the human female
nomic sequences in the
isks of HIV infection -
xpression in the female
solated from blood and
T on clinical evolution of
fast on the treatment of
xpression in the female
NA subtypes C and A in
/Socio-demography of
the panacea to female
n of HIV-1 in the female
omen with and without
n of HIV-1 in the female
equence in plasma and
V infection/Plasma and
mmonly used for female
Increasing incidence of
eripheral blood and the

/The role of the police and penitent 33411
/The "Projet Parc": AIDS preventio 34190
/AIDS prevention among migrant 245*/43379
between 1988 and 1995/HIV, hep 60440
Genital ulcer disease etiology by M-PCR i 22199
tract diseases in women undergoi 23464
reservoir and differential drug resis 334*/32279
transmission of SIVmac251 in cyn 33156
N. gonorrhoeae and C. trachomati 60783

genital tract/Co-receptors and cellular tar
tract of women/Analysis of full-len
tract infections among female sex
tract: Progesterone increases CC
fluid/Genotypic and biotypic chara
warts in HIV positive patients/Impa
discharge with Erythromycin tablet
tract following treatment of cervical
ulcers in patients attending STD Cli
infection with Chlamydia trachoma
cutting (FGC) and the associated ri
tract/Active production of HIV-1 in t
tract inflammation (GTI)/HIV DNA
tract: Association with HIV-1 in peri

10*/11106
11169
13577
335*/21109
21157
22192
22209
22310
23353
23373
23384
23442
23450
23488

ZT-resistant mutations/ Genotyping HIV-1 reverse transcriptase t
de serotyping and HMA genotyping in distinguishing HIV-1 subtyp
rmer USSR/Sero- and of HIV-1 variants circulating o
ities/HIV-1 sero- and of HIV/AIDS outbreak in Ukrai
he clinical utility of viral in HIV+ patients failing protea
arding the use of HIV-1 for a community consortium:
nhancement after viral in HIV+ patients failing highly
of response by protease /Nelfinavir in HAART-experie
neChip~ assay for HIV /Development of a new DNAmong women in Europe: Geographic diversity and time trends/The
drug users in Europe?/ variation in disease progressi
are for HIV-related PLP/ variations in quality of care for
s 2 recombinants and a geographic sub-cluster within subtype A/
ommunities: Assessing and cultural distances/HIV ed
vention studies/Using information systems to asses
o model the social and spread of HIV and STD/Meth
ogram/Determinants of mobility in a population-based
f Congo/Setting up a information systems (GIS) for
anza region, Tanzania/ Geographical variations in the prevalence
hool students in Tibilisi, Georgia /Knowledge, attitudes and practic
care settings in Atlanta, /Viral load and CD4+ outcome foil
ng population of Tbilisi, /Condom use among young popul
e Fed. University of M. Gerais, Brazil/Evaluation of knowledge, at
on in the United States/ Geriatric AIDS population study (GAPS) o
e antiretroviral therapy/ AIDS population study (GAPS):
efore AIDS diagnosis in German y data from the German AIDS regi
patients: Results of the Cidofovir Study Group/Clinical pr
multicenter evaluation ( AIDS Study Group GASG Protoc
se risk factors among gay men?/Are youth and drug us
IV-1 below 3% in the perinatal cohorts/Combining ZV
py-naive HIV-1 positive seroconvertors irrespective of vir
est and Central Africa ( Technical Corporation)/Added va
ssociated factors in a study group/Colonisation and dis
and AIDS network/The women and AIDS network/The
childbearing women in Germany - Unlinked anonymous testing o

41143
11193
13205
13209
32305
32307
32357
41215
42196
13181
192*/13338
60475
11186
13410
23217
43470
60556
60720
13119
14116
32291
33115
14120
23526
32417
13188
22256
22368
26*/23133
23291
41208
43224
60170
60708
13187

tract of women: Genital reservoir a 334*/32279
tract viral load and STDs in early HI 164*/42141
hygiene may contribute to the vagi 42370
ulcer disease in Durban, South Afri 60030
tract/Detection of HIV-1 in the oral 60608